Fingerprint
Dive into the research topics of 'Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006
Omid Hamid*, Caroline Robert, Antoni Ribas, F. Stephen Hodi, Euan Walpole, Adil Daud, Ana S. Arance, Ewan Brown, Christoph Hoeller, Laurent Mortier, Jacob Schachter, Jianmin Long, Scot Ebbinghaus, Nageatte Ibrahim, Marcus Butler
*Corresponding author for this work
- Angeles Clinic and Research Institute
- Université Paris-Saclay
- University of California at Los Angeles
- Dana-Farber Cancer Institute
- Princess Alexandra Hospital
- University of California at San Francisco
- Hospital Clinic Barcelona
- NHS Lothian
- Medical University of Vienna
- Université de Lille
- Sheba Medical Center at Tel Hashomer
- Merck
- Princess Margaret Hospital
Research output: Contribution to journal › Article › peer-review
134
Scopus
citations